TY - JOUR T1 - Analysis of alternative Covid-19 mitigation measures in school classrooms: an agent-based model of SARS-CoV-2 transmission JF - medRxiv DO - 10.1101/2021.08.30.21262826 SP - 2021.08.30.21262826 AU - M. J. Woodhouse AU - W. P. Aspinall AU - R. S. J. Sparks AU - CoMMinS Project “COVID-19 Mapping and Mitigation in Schools” Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/30/2021.08.30.21262826.abstract N2 - The SARS-CoV-2 epidemic has had major impacts on children’s education, with schools required to implement infection control measures that have led to long periods of absence and classroom closures. We develop an agent-based epidemiological model of SARS-CoV-2 transmission that is applied to model infection within school classrooms, with a contact model constructed using random networks informed by structured expert judgement. Mitigation strategies to control infection are modelled to allow analysis of their effectiveness in supressing infection outbreaks and in limiting pupil absence. The model is applied to re-examine Covid-19 in schools in the UK in autumn 2020, and to forecast infection levels in autumn 2021 when the more infectious Delta-variant is dominant and school transmission is likely to play a major role in a new wave of the epidemic. Our results indicate that testing-based surveillance of infections in the classroom population with isolation of positive cases is a more effective mitigation measure than bubble quarantine both for reducing transmission in schools and for avoiding pupil absence, even accounting for insensitivity of self-administered tests. Bubble quarantine results in large numbers of pupils absent from school, with only modest impact of classroom infection. However, maintaining a reduced contact rate within the classroom has a major beneficial impact for managing Covid-19 in school settings.Competing Interest StatementThe authors have declared no competing interest.Funding StatementMJW and WPA acknowledge funding from the "COVID-19 Mapping and Mitigation in Schools" (CoMMinS) project which is supported by the Medical Research Council (grant no. MR/V0285545/1) and hosted within the UK MRC Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/5). There was no direct funding for this study but the support of the Royal Society RAMP initiative for COVID-19 is acknowledged. MJW also acknowledges funding from NERC on fellowship NE/R003890/1.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:University of BristolAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is available on request from mark.woodhouse{at}bristol.ac.uk ER -